Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial - Concepedia

Concepedia

Publication | Open Access

Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial

DOI Full Paper Access

68

Citations

19

References

2021

Year

Paul Cremer, Antonio Abbate, Kristin Hudock, Carla McWilliams, J.P. Mehta, Steven Y. Chang, Calvin C. Sheng, Benjamín Van Tassell, Aldo Bonaventura, Alessandra Vecchié,

The Lancet Rheumatology

References

	Year	Citations

Page 1